Latest Insider Transactions at Organicell Regenerative Medicine, Inc. (OCEL)
This section provides a real-time view of insider transactions for Organicell Regenerative Medicine, Inc. (OCEL). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Organicell Regenerative Medicine, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Organicell Regenerative Medicine, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 21
2020
|
Michael Carbonara Director |
BUY
Open market or private purchase
|
Indirect |
1,000,000
+2.13%
|
-
|
|
Dec 21
2020
|
Allen James Meglin Director |
BUY
Open market or private purchase
|
Direct |
1,000,000
+6.41%
|
-
|
|
Dec 21
2020
|
Maria Ines Mitrani Chief Science Officer |
BUY
Grant, award, or other acquisition
|
Direct |
15,000,000
+12.62%
|
-
|
|
Oct 16
2020
|
Allen James Meglin Director |
BUY
Open market or private purchase
|
Direct |
625,000
+4.4%
|
$0
$0.08 P/Share
|
|
Sep 23
2020
|
Albert Mitrani Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,000,000
+5.34%
|
$0
$0.28 P/Share
|
|
Sep 23
2020
|
Ian T Bothwell Interim CEO & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
7,000,000
+6.23%
|
$0
$0.28 P/Share
|
|
Sep 23
2020
|
Maria Ines Mitrani Chief Science Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,000,000
+8.66%
|
$0
$0.28 P/Share
|
|
Sep 23
2020
|
George Craig Shapiro Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,000,000
+10.07%
|
$0
$0.28 P/Share
|
|
Sep 17
2020
|
Albert Mitrani Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,000,000
+3.47%
|
$0
$0.03 P/Share
|
|
Sep 17
2020
|
Ian T Bothwell Interim CEO & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
5,000,000
+3.99%
|
$0
$0.03 P/Share
|
|
Sep 17
2020
|
Maria Ines Mitrani Chief Science Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,000,000
+5.33%
|
$0
$0.03 P/Share
|
|
Sep 17
2020
|
George Craig Shapiro Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,000,000
+6.06%
|
$0
$0.03 P/Share
|
|
Sep 03
2020
|
Albert Mitrani Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,000,000
+3.59%
|
$0
$0.03 P/Share
|
|
Sep 03
2020
|
Ian T Bothwell Interim CEO & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
5,000,000
+4.16%
|
$0
$0.03 P/Share
|
|
Sep 03
2020
|
Maria Ines Mitrani Chief Science Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,000,000
+5.63%
|
$0
$0.03 P/Share
|
|
Sep 03
2020
|
George Craig Shapiro Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,000,000
+6.45%
|
$0
$0.03 P/Share
|
|
Aug 25
2020
|
Albert Mitrani Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,000,000
+3.73%
|
$0
$0.03 P/Share
|
|
Aug 25
2020
|
Ian T Bothwell Interim CEO & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
5,000,000
+4.34%
|
$0
$0.03 P/Share
|
|
Aug 25
2020
|
Maria Ines Mitrani Chief Science Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,000,000
+5.96%
|
$0
$0.03 P/Share
|
|
Aug 25
2020
|
George Craig Shapiro Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,000,000
+6.9%
|
$0
$0.03 P/Share
|